These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 30125307)
1. Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis. Peiseler M; Reiners D; Pinnschmidt HO; Sebode M; Jung F; Hartl J; Zenouzi R; Ehlken H; Groth S; Schachschal G; Rösch T; Weiler-Normann C; Lohse AW; Schramm C PLoS One; 2018; 13(8):e0202686. PubMed ID: 30125307 [TBL] [Abstract][Full Text] [Related]
2. Deterioration of cholestasis after endoscopic retrograde cholangiography in advanced primary sclerosing cholangitis. Beuers U; Spengler U; Sackmann M; Paumgartner G; Sauerbruch T J Hepatol; 1992 May; 15(1-2):140-3. PubMed ID: 1506631 [TBL] [Abstract][Full Text] [Related]
3. Sclerosing cholangitis with autoimmune pancreatitis versus primary sclerosing cholangitis: comparison on endoscopic retrograde cholangiography, MR cholangiography, CT, and MRI. Kim JH; Byun JH; Kim SY; Lee SS; Kim HJ; Kim MH; Lee MG Acta Radiol; 2013 Jul; 54(6):601-7. PubMed ID: 23528564 [TBL] [Abstract][Full Text] [Related]
4. Prophylaxis of post-ERC infectious complications in patients with biliary obstruction by adding antimicrobial agents into ERC contrast media- a single center retrospective study. Wobser H; Gunesch A; Klebl F BMC Gastroenterol; 2017 Jan; 17(1):10. PubMed ID: 28086796 [TBL] [Abstract][Full Text] [Related]
5. Predictors of successful clinical and laboratory outcomes in patients with primary sclerosing cholangitis undergoing endoscopic retrograde cholangiopancreatography. Enns R; Eloubeidi MA; Mergener K; Jowell PS; Branch MS; Baillie J Can J Gastroenterol; 2003 Apr; 17(4):243-8. PubMed ID: 12704468 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis of primary sclerosing cholangitis: a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography. Moff SL; Kamel IR; Eustace J; Lawler LP; Kantsevoy S; Kalloo AN; Thuluvath PJ Gastrointest Endosc; 2006 Aug; 64(2):219-23. PubMed ID: 16860072 [TBL] [Abstract][Full Text] [Related]
7. Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma. Boyd S; Mustonen H; Tenca A; Jokelainen K; Arola J; Färkkilä MA Scand J Gastroenterol; 2017 Feb; 52(2):242-249. PubMed ID: 27806633 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for complications of ERCP in primary sclerosing cholangitis. Ismail S; Kylänpää L; Mustonen H; Halttunen J; Lindström O; Jokelainen K; Udd M; Färkkilä M Endoscopy; 2012 Dec; 44(12):1133-8. PubMed ID: 23108808 [TBL] [Abstract][Full Text] [Related]
9. Changes in liver stiffness using acoustic radiation force impulse imaging in patients with obstructive cholestasis and cholangitis. Attia D; Pischke S; Negm AA; Rifai K; Manns MP; Gebel MJ; Lankisch TO; Potthoff A Dig Liver Dis; 2014 Jul; 46(7):625-31. PubMed ID: 24666759 [TBL] [Abstract][Full Text] [Related]
10. Comparison of intraductal ultrasonography findings between primary sclerosing cholangitis and IgG4-related sclerosing cholangitis. Naitoh I; Nakazawa T; Hayashi K; Miyabe K; Shimizu S; Kondo H; Nishi Y; Yoshida M; Umemura S; Hori Y; Kato A; Okumura F; Sano H; Ohara H; Joh T J Gastroenterol Hepatol; 2015 Jun; 30(6):1104-9. PubMed ID: 25594435 [TBL] [Abstract][Full Text] [Related]
12. Antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitis. Lenzen H; Weismüller TJ; Negm AA; Wlecke J; Loges S; Strassburg CP; Manns MP; Lankisch TO Scand J Gastroenterol; 2013 Oct; 48(10):1205-12. PubMed ID: 23957616 [TBL] [Abstract][Full Text] [Related]
13. Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: risk factors for biliary neoplasia. Boyd S; Tenca A; Jokelainen K; Mustonen H; Krogerus L; Arola J; Färkkilä MA Endoscopy; 2016 May; 48(5):432-9. PubMed ID: 26808393 [TBL] [Abstract][Full Text] [Related]
14. Endoscopic treatment for biliary stricture after adult living donor liver transplantation. Seo JK; Ryu JK; Lee SH; Park JK; Yang KY; Kim YT; Yoon YB; Lee HW; Yi NJ; Suh KS Liver Transpl; 2009 Apr; 15(4):369-80. PubMed ID: 19326412 [TBL] [Abstract][Full Text] [Related]
16. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Tischendorf JJ; Krüger M; Trautwein C; Duckstein N; Schneider A; Manns MP; Meier PN Endoscopy; 2006 Jul; 38(7):665-9. PubMed ID: 16673310 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis. Berstad AE; Aabakken L; Smith HJ; Aasen S; Boberg KM; Schrumpf E Clin Gastroenterol Hepatol; 2006 Apr; 4(4):514-20. PubMed ID: 16616358 [TBL] [Abstract][Full Text] [Related]
18. Elevated Serum Bilirubin Level Correlates With the Development of Cholangiocarcinoma, Subsequent Liver Transplantation, and Death in Patients With Primary Sclerosing Cholangitis. Haseeb A; Siddiqui A; Taylor LJ; Cox K; Adler DG J Clin Gastroenterol; 2016; 50(5):431-5. PubMed ID: 26927495 [TBL] [Abstract][Full Text] [Related]
19. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis. Boyd S; Vannas M; Jokelainen K; Isoniemi H; Mäkisalo H; Färkkilä MA; Arola J World J Gastroenterol; 2017 Sep; 23(33):6147-6154. PubMed ID: 28970730 [TBL] [Abstract][Full Text] [Related]